Skip to content

NO LyMIT: Lymphoma Microenvironment & Immune Therapies

US Focus Meeting 2026


📍 Le Méridien New Orleans, 333 Poydras St, New Orleans, LA 70130

🗓️ October 23 - 24, 2026


Last Year's Highlights

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the NO LyMIT: Lymphoma Microenvironment & Immune Therapies Focus Meeting 2026, to be held on October 23 - 24, 2026.  

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing NO LyMIT: Lymphoma Microenvironment & Immune Therapies research and patient treatment.  

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of NO LyMIT: Lymphoma Microenvironment & Immune Therapies US Focus Meeting 2026:

Christopher-Flowers

Christopher Flowers
MD Anderson Cancer Center, Houston, TX


Michael-Green

Michael R. Green
MD Anderson Cancer Center, Houston, TX


Supporters to be announced...
Interested in supporting this meeting? Get in contact:
neve.rowlands@md-education.com

Agenda & Faculty

October 23, 2026 | Day 1  

11:00 AM
Registration Opens
11:15 AM
Industry Supported Independent Expert Discussion
12:00 PM
Introduction From the Chairs

Session I: TBD
Moderated by:

TBD

TBD
TBD
12:30 PM
CART Cells

YL

Yi Lin, MD
Mayo Clinic, Rochester, MN
12:50 PM
Bispecific Antibodies
Jennifer-Crombie
Jennifer Crombie
Dana-Farber Cancer Institute, Boston, MA
01:10 PM
Targeting Macrophage Biology
Ryan-Wilcox
Ryan Wilcox
University of Michigan Health, Ann Arbor, MI
01:30 PM
Small Molecule Modulation of the Microenvironment
John-Teijaro
John Teijaro
Scripps Research Institute La Jolla, CA
01:50 PM
Panel Discussion
02:10 PM
Coffee Break

Session II: Biology of Immune Deregulation in Lymphoma
Moderated by:

Michael-Green
Michael R. Green
MD Anderson Cancer Center, Houston, TX
02:30 PM
Genetic and Epigenetic Regulation of the Microenvironment
Samuel-Yamshon
Samuel Yamshon
NYU Langone Medical Center, New York, NY
02:50 PM
The microbiome and CAR T cell response and toxicity

MS

Melody Smith, MD
Stanford Medicine, CA
03:10 PM
Spatial Organization of the Microenvironment
Michael-Green
Michael Green
MD Anderson Cancer Center, Houston, TX
03:30 PM
Kinase-driven immunotherapeutic targets in ALCL identified by N glycoproteomics
Megan-Lim
Megan Lim
Memorial Sloan Kettering Cancer Center, New York, NY
03:50 PM
Panel Discussion
04:10 PM
Coffee Break
04:30 PM
Plenary Presentation

TBD

KOL TBD
TBD
05:10 PM
Adjourn

October 24, 2026 | Day 2

08:00 AM
Registration Opens
08:15 AM
Industry Supported Independent Expert Discussion

Session III: Overcoming Challenges for Cell and Immune Therapies
Moderated by:

TBD

TBD
TBD
09:00 AM
Non-Relapse Mortality
Mark-Hamilton
Mark Hamilton
Stanford Medicine, CA
09:20 AM
Platforms for Improving Lymphoma Therapy
Jean-Koff
Jean Koff
Emory Winship Cancer Institute, Atlanta, GA
09:40 AM
How the Microbiome Impacts Cell Therapy

TBD

TBD
TBD
10:00 AM
Avoiding Pitfalls in Immunotherapy Trials
Jeremy-Abramson
Jeremy Abramson
Massachusetts General Hospital, Boston, MA
10:20 AM
Panel Discussion
10:40 AM
Lunch Break

Session IV: Targeted Strategies for Lymphoma Microenvironments
Moderated by:

TBD

TBD
TBD
11:30 AM
Strategies for Rare Lymphomas

JV

Julie Vose
University of Nebraska Medical Center, Omaha, NE
11:50 AM
Immunotherapy for T-cell Lymphomas
Pamela-Allen
Pamela Allen
Emory Winship Cancer Institute, Atlanta, GA
12:10 PM
Novel Cell Therapy Engineering
Todd-Fehniger
Todd Fehniger
Washington University School of Medicine, St. Louis, MO
12:30 PM
New CARs and TCEs

TBD

TBD
Industry
12:50 PM
Panel Discussion
01:10 PM
Coffee Break

Session V: Future Perspectives for Microenvironment Clinical Trials
Moderated by:

TBD

TBD
TBD
01:30 PM
Biomarkers for Immunotherapy

JG

James Godfrey
City of Hope, Duarte, CA
01:50 PM
Digital Pathology

JS

Jansen Seheult
Mayo Clinic, Rochester, MN
02:10 PM
Translating Microenvironment Selection to the Clinic
Stephen-Ansell
Stephen Ansell
Mayo Clinic, Rochester, MN
02:30 PM
How to Design a Lymphoma Basket Trial
Caron-Jacobson
Caron Jacobson
Dana-Farber Cancer Institute, Boston, MA
02:50 PM
Panel Discussion
03:10 PM
Special Emphasis Panel: Integration of Microenvironment and Genomic Characterization into Clinical Trials
03:40 PM
Adjourn

Neve Rowlands
Project Manager

How long has Neve Rowlands been in the business?

Neve Rowlands has been with MD Education since 2023

About Neve Rowlands

I am a dedicated project manager in the hematology industry, with a current focus on CLL and lymphoma. Specialising in logistical organisation with a sharp eye for detail, and committed to delivering high-quality, seamless events. The most rewarding part of the role is watching meetings come to life. I am passionate about connecting with both familiar and new faces, and driven by the impact of well-executed projects that support meaningful progress in the field.

Screenshot 2026-01-20 at 10.55.42